1-2 of 2
Philipp A. Greif
Close
Sort by
Journal Articles

Differential impact of IDH1 / 2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Clinical Trials & Observations
Jan M. Middeke, Klaus H. Metzeler, Christoph Röllig, Michael Krämer, Jan-Niklas Eckardt, Sebastian Stasik, Philipp A. Greif, Karsten Spiekermann, Maja Rothenberg-Thurley, Utz Krug, Jan Braess, Alwin Krämer, Andreas Hochhaus, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Dennis Görlich, Cristina Sauerland, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Martin Kaufmann, Desiree Kunadt, Bernhard Wörmann, Katja Sockel, Malte von Bonin, Tobias Herold, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Claudia D. Baldus, Gerhard Ehninger, Johannes Schetelig, Wolfgang Hiddemann, Martin Bornhäuser, Friedrich Stölzel, Christian Thiede
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1394–1405.
https://doi.org/10.1182/bloodadvances.2021004934
Published: 2022
Includes: Supplemental data
Journal Articles

A clinically applicable gene expression–based score predicts resistance to induction treatment in acute myeloid leukemia

Clinical Trials & Observations
Christian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, Bianka Ksienzyk, Aarif M. N. Batcha, Annika Dufour, Stephanie Schneider, Maja Rothenberg-Thurley, Cristina M. Sauerland, Dennis Görlich, Wolfgang E. Berdel, Utz Krug, Ulrich Mansmann, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Philipp A. Greif, Sebastian Vosberg, Klaus H. Metzeler, Jörg Kumbrink, Tobias Herold
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4752–4761.
https://doi.org/10.1182/bloodadvances.2021004814
Published: 2021
Includes: Supplemental data